L.J. Altfest & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $547K | Buy |
+1,042
| New | +$547K | 0.06% | 202 |
|
|
2024
Q4 | – | Sell |
-1,019
| Closed | -$1.07M | – | 360 |
|
|
2024
Q3 | $1.07M | Buy |
1,019
+21
| +2% | +$22.1K | 0.14% | 122 |
|
|
2024
Q2 | $1.05M | Buy |
998
+15
| +2% | +$15.8K | 0.14% | 111 |
|
|
2024
Q1 | $946K | Buy |
983
+18
| +2% | +$17.3K | 0.13% | 123 |
|
|
2023
Q4 | $848K | Sell |
965
-3
| -0.3% | -$2.64K | 0.12% | 127 |
|
|
2023
Q3 | $797K | Buy |
968
+7
| +0.7% | +$5.76K | 0.13% | 130 |
|
|
2023
Q2 | $691K | Sell |
961
-9
| -0.9% | -$6.47K | 0.1% | 138 |
|
|
2023
Q1 | $797K | Hold |
970
| – | – | 0.12% | 115 |
|
|
2022
Q4 | $700K | Sell |
970
-12
| -1% | -$8.66K | 0.12% | 120 |
|
|
2022
Q3 | $676K | Buy |
982
+19
| +2% | +$13.1K | 0.13% | 111 |
|
|
2022
Q2 | $569K | Hold |
963
| – | – | 0.1% | 135 |
|
|
2022
Q1 | $673K | Buy |
963
+36
| +4% | +$25.2K | 0.12% | 127 |
|
|
2021
Q4 | $585K | Buy |
927
+3
| +0.3% | +$1.89K | 0.11% | 135 |
|
|
2021
Q3 | $559K | Sell |
924
-7
| -0.8% | -$4.24K | 0.12% | 129 |
|
|
2021
Q2 | $520K | Sell |
931
-14
| -1% | -$7.82K | 0.11% | 137 |
|
|
2021
Q1 | $447K | Buy |
+945
| New | +$447K | 0.11% | 156 |
|
|
2020
Q1 | – | Sell |
-1,294
| Closed | -$486K | – | 224 |
|
|
2019
Q4 | $486K | Sell |
1,294
-454
| -26% | -$171K | 0.12% | 108 |
|
|
2019
Q3 | $485K | Buy |
1,748
+29
| +2% | +$8.05K | 0.13% | 103 |
|
|
2019
Q2 | $538K | Buy |
+1,719
| New | +$538K | 0.14% | 99 |
|